Category - News

Executive Moves

Titan Pharma hires commercialization veteran, Dane Hallberg

Titan Pharmaceuticals (NASDAQ:TTNP) appointed Dane Hallberg to the newly created position of EVP and chief commercial officer, effective immediately, with responsibility for leading all of the company’s commercial...

October 2, 2018

Executive Moves

Ondine Biomedical names Cameron Lawrence as COO, CFO

Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.

October 1, 2018

Markets

Ladenburg starts Oncolytics Biotech at buy; PT $22

Ladenburg Thalmann launched coverage of Oncolytics Biotech (NASDAQ:ONCY) with a “buy” rating and $22 price target. The stock closed at $3.86 on Sept. 28. Oncolytics is developing oncolytic virus (OV) therapy for cancer...

October 1, 2018

Executive Moves

Raymond James names Dane Leone as a managing director in biotech research

Raymond James appointed Dane Leone as a managing director responsible for biotechnology coverage in the firm’s equity research department.

October 1, 2018

Markets

Ladenburg starts Neon Therapeutics at buy; PT $20

Ladenburg Thalmann initiated coverage of Neon Therapeutics (NASDAQ: NTGN) with a “buy” rating and $20 price target. The stock closed at $8.54 on Sept. 28. “We believe NEO-PV-01 enjoys a powerful first mover advantage in...

October 1, 2018

Developments

BioLight completes second stage in sale of IOPtima unit

BioLight Life Sciences (OTCQX:BLGTY; TASE:BOLT) has completed the second stage of the investment in and acquisition in stages of its subsidiary, IOPtima, by Chengdu Kanghong Pharmaceutical Group of China. Under the...

September 27, 2018

Markets

WB starts Restoration Robotics at OP

William Blair launched coverage of Restoration Robotics (NASDAQ:HAIR) with an “outperform” rating. The stock closed at $2.54 on Sept. 25. “With recent FDA approval of its latest-generation device, Restoration Robotics’...

September 26, 2018

Markets

Roth starts Bionano Genomics at buy; PT $12

Roth Capital Partners initiated coverage of Bionano Genomics (NASDAQ:BNGO) with a “buy” rating and $12 price target. The stock closed at $6.31 on Sept. 24. Bionano is a life sciences instrumentation company that offers...

September 25, 2018

Executive Moves

3DS names Sherif Louis as CEO

3D Signatures (TSX:DXD) appointed Sherif Louis, as the company's chief executive officer.

September 25, 2018

Developments

IntelGenx beginning patient screening in Phase 2a Montelukast VersaFilm trial in AD

IntelGenx (TSXV:IGX; OTCQX:IGXT) announced that patient recruitment would begin for a Phase 2a study with Montelukast VersaFilm in patients with mild-to-moderate Alzheimer’s Disease (AD). Two research sites in Toronto...

September 25, 2018

Category - News

Subscribe